Preoperative radiotherapy may improve the resectability and subsequent local control of rectal cancers. However, the extent of radiation induced regression in these tumours varies widely between individuals. To date no reliable predictive marker of radiation sensitivity in rectal cancer has been identified. At the cellular level, radiation injury initiates a complex molecular network of DNA damage response (DDR) pathways that leads to cell cycle arrest, attempts at re-constituting the damaged DNA and should this fail, then apoptosis. This review presents the details which suggest the roles of DNA mismatch repair proteins, the lack of which define a distinct subset of colorectal cancers with microsatellite instability (MSI), in the DDR pathways. Hence routine assessment of the MSI status in rectal cancers may potentially serve as a predictor of radiotherapy response, thereby improving patient stratification in the administration of this otherwise toxic treatment.

Citations

Citations to this article as recorded by  

• Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
  Sung Uk Bae, Hye Won Lee, Jee Young Park, Incheol Seo, Jae-Min Cho, Jin Young Kim, Ju Yup Lee, Yoo Jin Lee, Seong Kyu Baek, Nam Kyu Kim, Sang Jun Byun, Shin Kim
  Clinical and Translational Radiation Oncology.2025; 51: 100906.     CrossRef
• Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands
  Eline G.M. van Geffen, Cornelis R.C. Hogewoning, Sanne-Marije J.A. Hazen, Tania C. Sluckin, Marilyne M. Lange, Petur Snaebjornsson, Regina G.H. Beets-Tan, Corrie A.M. Marijnen, Cornelis Verhoef, Myriam Chalabi, Pieter J. Tanis, Miranda Kusters, Tjeerd S.
  Clinical Colorectal Cancer.2024;[Epub]     CrossRef
• Potential risks associated with the use of ionizing radiation for imaging and treatment of colorectal cancer in Lynch syndrome patients
  Mingzhu Sun, Jayne Moquet, Michele Ellender, Simon Bouffler, Christophe Badie, Rachel Baldwin-Cleland, Kevin Monahan, Andrew Latchford, David Lloyd, Susan Clark, Nicola A. Anyamene, Elizabeth Ainsbury, David Burling
  Familial Cancer.2023; 22(1): 61.     CrossRef
• Not All Patients With Locally Advanced Rectal Cancer Benefit From Neoadjuvant Therapy
  Carolyn Chang, Jonathan T. Bliggenstorfer, Jessie Liu, Jennifer Shearer, Paul Dreher, Katherine Bingmer, Sharon L. Stein, Emily Steinhagen
  The American Surgeon™.2023; 89(11): 4327.     CrossRef
• Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone
  Kemin Ni, Yixiang Zhan, Zhaoce Liu, Zhen Yuan, Shuyuan Wang, Xuan-zhu Zhao, Hangyu Ping, Yaohong Liu, Wanting Wang, Suying Yan, Ran Xin, Qiurong Han, Qinghuai Zhang, Guoxun Li, Xipeng Zhang, Guihua Wang, Zili Zhang, Hong Ma, Chunze Zhang
  BMC Cancer.2023;[Epub]     CrossRef
• Rectal Cancer in Patients with Hereditary Nonpolyposis Colorectal Cancer Compared with Sporadic Cases: Response to Neoadjuvant Chemoradiation and Local Recurrence
  Khaled M Madbouly, Sameh Hany Emile, Yasmine Amr Issa
  Journal of the American College of Surgeons.2022; 234(5): 793.     CrossRef
• Molecular Recognition and Quantification of MLH1, MSH2, MSH6, PMS2, and KRAS in Biological Samples
  Raluca-Ioana Stefan-van Staden, Ruxandra-Maria Ilie-Mihai, Maria Coros, Stela Pruneanu
  ECS Sensors Plus.2022; 1(3): 031606.     CrossRef
• Magnetic Resonance Imaging Downstaging, Pathological Response, and Microsatellite Instability Status in Patients with Signet-Ring Cell Carcinoma Rectum Undergoing Preoperative Long-course Chemoradiation
  B. Rajkrishna, Saikat Das, Dipti Masih, Tharani Putta, Rajat Raghunath, Thomas Samuel Ram
  Current Medical Issues.2022; 20(3): 154.     CrossRef
• Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
  Aylin Alkan, Tobias Hofving, Eva Angenete, Ulf Yrlid
  Biomarker Research.2021;[Epub]     CrossRef
• Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer
  Shaakir Hasan, Paul Renz, Rodney E. Wegner, Gene Finley, Moses Raj, Dulabh Monga, James McCormick, Alexander Kirichenko
  Annals of Surgery.2020; 271(4): 716.     CrossRef
• Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
  Éanna J. Ryan, Ben Creavin, Kieran Sheahan
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
  Shu-Biao Ye, Yi-Kan Cheng, Lin Zhang, Yi-Feng Zou, Ping Chen, Yan-Hong Deng, Yan Huang, Jian-Hong Peng, Xiao-Jian Wu, Ping Lan
  npj Precision Oncology.2020;[Epub]     CrossRef
• Implication of expression of MMR proteins and clinicopathological characteristics in gastric cancer
  Renu Verma, Puja Sakhuja, Ritu Srivastava, Prakash Chand Sharma
  Asia-Pacific Journal of Oncology.2020; : 1.     CrossRef
• Mismatch Repair–Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy
  Andrea Cercek, Gustavo Dos Santos Fernandes, Campbell S. Roxburgh, Karuna Ganesh, Shu Ng, Francisco Sanchez-Vega, Rona Yaeger, Neil H. Segal, Diane L. Reidy-Lagunes, Anna M. Varghese, Arnold Markowitz, Chao Wu, Bryan Szeglin, Charles-Etienne Gabriel Sauvé
  Clinical Cancer Research.2020; 26(13): 3271.     CrossRef
• The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review
  Maria Cilona, Luca Giovanni Locatello, Luca Novelli, Oreste Gallo
  Cancers.2020; 12(10): 3006.     CrossRef
• Genetics of rectal cancer and novel therapies: primer for radiologists
  Sebastian Mondaca, Rona Yaeger
  Abdominal Radiology.2019; 44(11): 3743.     CrossRef
• Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer
  Casper Reijnen, Heidi V.N. Küsters-Vandevelde, Clemens F. Prinsen, Leon F.A.G. Massuger, Marc P.M.L. Snijders, Stefan Kommoss, Sara Y. Brucker, Janice S. Kwon, Jessica N. McAlpine, Johanna M.A. Pijnenborg
  Gynecologic Oncology.2019; 154(1): 124.     CrossRef
• Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
  Nicolas Meillan, Dewi Vernerey, Jérémie H. Lefèvre, Gilles Manceau, Magali Svrcek, Jeremy Augustin, Jean-François Fléjou, Olivier Lascols, Jean-Marc Simon, Romain Cohen, Philippe Maingon, Jean-Baptiste Bachet, Florence Huguet
  International Journal of Radiation Oncology*Biology*Physics.2019; 105(4): 824.     CrossRef
• Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients
  Sally M. Shalaby, Amal S. El-Shal, Lobna A. Abdelaziz, Eman Abd-Elbary, Mostafa M. Khairy
  Gene.2018; 644: 66.     CrossRef
• RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer
  Chao Xiao, Yupeng Wang, Miao Zheng, Jian Chen, Guohe Song, Zhijie Zhou, Chongzhi Zhou, Xing Sun, Lin Zhong, Erxun Ding, Yi Zhang, Liu Yang, Gang Wu, Shifeng Xu, Hong Zhang, Xiaoliang Wang
  Cancer Science.2018; 109(4): 1075.     CrossRef
• Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K)
  Stefan Eder, Annette Arndt, Andreas Lamkowski, Wassiliki Daskalaki, Alexis Rump, Markus Priller, Felicitas Genze, Eva Wardelmann, Matthias Port, Konrad Steinestel
  Cancer Letters.2017; 385: 160.     CrossRef
• The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing
  E. Ryan, K. Sheahan, B. Creavin, H.M. Mohan, D.C. Winter
  Critical Reviews in Oncology/Hematology.2017; 116: 38.     CrossRef
• Exploration of Mutation and DNA Methylation of Polo-Like Kinase 1 (PLK1) in Colorectal Cancer
  Wayne Ng, Joo-Shik Shin, Bin Wang, Cheok Soon Lee
  Open Journal of Pathology.2017; 07(03): 45.     CrossRef
• Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland
  Katarzyna Karpińska-Kaczmarczyk, Magdalena Lewandowska, Małgorzata Ławniczak, Andrzej Białek, Elżbieta Urasińska
  Medical Science Monitor.2016; 22: 2886.     CrossRef
• DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics
  Nicole de Rosa, Miguel A. Rodriguez-Bigas, George J. Chang, Jula Veerapong, Ester Borras, Sunil Krishnan, Brian Bednarski, Craig A. Messick, John M. Skibber, Barry W. Feig, Patrick M. Lynch, Eduardo Vilar, Y. Nancy You
  Journal of Clinical Oncology.2016; 34(25): 3039.     CrossRef
• miRNA-148b regulates radioresistance in non-small lung cancer cells via regulation of MutL homologue 1
  Guangsheng Zhai, Gaozhong Li, Bo Xu, Tongfu Jia, Yinping Sun, Jianbo Zheng, Jianbin Li
  Bioscience Reports.2016;[Epub]     CrossRef
• Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
  S.H. Lim, W. Chua, C. Henderson, W. Ng, J.-S. Shin, L. Chantrill, R. Asghari, C.S. Lee, K.J. Spring, P. de Souza
  Critical Reviews in Oncology/Hematology.2015; 96(1): 67.     CrossRef
• Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers
  Ruth Exner, Walter Pulverer, Martina Diem, Lisa Spaller, Laura Woltering, Martin Schreiber, Brigitte Wolf, Markus Sonntagbauer, Fabian Schröder, Judith Stift, Fritz Wrba, Michael Bergmann, Andreas Weinhäusel, Gerda Egger
  British Journal of Cancer.2015; 113(7): 1035.     CrossRef
• Study of Liver Transplant Rejection in Alcoholism-Induced Cirrhosis
  J. Tinoco González, C. Bernal Bellido, G. Jimenez Riera, V. Camacho Marente, L.M. Marín Gómez, G. Suárez Artacho, J.M. Álamo Martínez, J. Serrano Díez-Canedo, R.J. Padillo Ruíz, M.A. Gómez Bravo
  Transplantation Proceedings.2013; 45(10): 3650.     CrossRef